Molly Lee, FAMILY NURSE PRACTIO
Family · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Molly Lee’s office at (408) 503-7600 to ask if they take your plan before you enroll.
Drugs they prescribed that Part D paid
$13,709
Pharmacies billed $13,709 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 168) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
143 generic and fewer than 11 brand-name prescriptions · $13,709 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Atorvastatin | 34 | $188 | $6 |
| Metformin | 14 | $71 | $5 |
| Lisinopril | 11 | $66 | $6 |
| Amlodipine Besylate | 12 | $43 | $4 |
Year by year
| 2024 | 168 | 50 | 0% (0) | None | $13,709 |
| 2023 | 684 | 149 | None | 17% | $76,227 |
| 2022 | 881 | 212 | 0% (0) | 17% | $107,322 |
| 2021 | 780 | 179 | 0% (0) | 22% | $108,456 |
| 2020 | 249 | 80 | 0% (0) | 25% | $33,882 |
| 2019 | 15 | None | 0% (0) | None | $8,657 |
| 2018 | 355 | 113 | None | 13% | $35,597 |
| 2017 | 218 | 92 | None | None | $11,251 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 14 drugs
| Jardiance | 11 | $8,909 | $810 |
| Humulin N Kwikpen | 11 | $6,518 | $593 |
| Toujeo Solostar | 12 | $5,417 | $451 |
| Atorvastatin | 90 | $903 | $10 |
| Albuterol Sulfate Hfa | 28 | $721 | $26 |
| Metoprolol | 20 | $621 | $31 |
| Metformin | 50 | $319 | $6 |
| Losartan | 33 | $274 | $8 |
| Tamsulosin | 12 | $261 | $22 |
| Gabapentin | 19 | $210 | $11 |
| Lisinopril | 48 | $207 | $4 |
| Amlodipine Besylate | 32 | $163 | $5 |
| Furosemide | 27 | $95 | $4 |
| Simvastatin | 14 | $70 | $5 |
2022: 18 drugs
| Humulin N Kwikpen | 13 | $18,063 | $1,389 |
| Jardiance | 13 | $6,112 | $470 |
| Atorvastatin | 79 | $1,193 | $15 |
| Nano 2nd Gen Pen Needle | 18 | $1,154 | $64 |
| Albuterol Sulfate Hfa | 31 | $1,094 | $35 |
| Losartan | 53 | $541 | $10 |
| Metformin | 64 | $483 | $8 |
| Metoprolol | 18 | $398 | $22 |
| Tamsulosin | 28 | $391 | $14 |
| Amlodipine Besylate | 50 | $290 | $6 |
| Lisinopril | 56 | $280 | $5 |
| Gabapentin | 28 | $234 | $8 |
| Glipizide | 30 | $175 | $6 |
| Omeprazole | 20 | $135 | $7 |
| Furosemide | 33 | $113 | $3 |
| Metformin Hcl Er | 15 | $111 | $7 |
| Simvastatin | 13 | $78 | $6 |
| Hydrochlorothiazide | 11 | $24 | $2 |
2021: 18 drugs
| Humulin N Kwikpen | 14 | $17,525 | $1,252 |
| Humulin 70/30 Kwikpen | 17 | $14,558 | $856 |
| Spiriva Respimat | 23 | $11,150 | $485 |
| Jardiance | 12 | $7,933 | $661 |
| Humulin N | 13 | $3,808 | $293 |
| Albuterol Sulfate Hfa | 27 | $722 | $27 |
| Losartan | 52 | $605 | $12 |
| Atorvastatin | 40 | $518 | $13 |
| Gabapentin | 21 | $313 | $15 |
| Lisinopril | 67 | $237 | $4 |
| Tamsulosin | 20 | $180 | $9 |
| Metformin | 37 | $176 | $5 |
| Omeprazole | 19 | $151 | $8 |
| Amlodipine Besylate | 40 | $140 | $4 |
| Glipizide | 14 | $87 | $6 |
| Furosemide | 19 | $78 | $4 |
| Simvastatin | 12 | $71 | $6 |
| Hydrochlorothiazide | 11 | $59 | $5 |
2020: 2 drugs
| Humulin 70/30 Kwikpen | 13 | $11,789 | $907 |
| Fluticasone Propionate | 12 | $78 | $6 |
2018: 7 drugs
| Diclofenac | 15 | $649 | $43 |
| Omeprazole | 18 | $216 | $12 |
| Escitalopram | 12 | $209 | $17 |
| Simvastatin | 14 | $148 | $11 |
| Metformin | 11 | $145 | $13 |
| Fluticasone Propionate | 14 | $144 | $10 |
| Amlodipine Besylate | 17 | $56 | $3 |
2017: 2 drugs
| Diclofenac | 11 | $478 | $43 |
| Fluticasone Propionate | 11 | $124 | $11 |
Money from drug and device companies
$46 in 2025
| 2025 | 2 | 2 | None | $46 |
| 2023 | 1 | 1 | None | $13 |
| 2022 | 1 | 1 | None | $30 |
| 2021 | 1 | 1 | None | $17 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
See all 2 published payments
| Dexcom | Meals · 2025-10-01 | Dexcom G6 Transmitter | $28 |
| Medtronic | Meals · 2025-08-06 | Sonicision | $18 |
See earlier years (2023, 2022, 2021)
2023: $13
| CooperSurgical | Endosee | $13 | 1 payment
|
2022: $30
| Abbvie | Lo Loestrin Fe | $30 | 1 payment
|
2021: $17
| AbbVie | Vraylar | $17 | 1 payment
|
Professional record
- NPI
- 1134655897
- Licence
- CA 95006487
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LF0000X (363LF0000X)
- Mailing address
- 903 E. Devonshire Ave, Hemet, CA, 92543
- NPI first listed
- 2017-05-02
- NPI last updated
- 2020-07-09
- NPI record certified
- 2020-07-09
This is when the NPI record was last certified, not a medical board exam.